Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Jun;27(1):475-489.
doi: 10.1007/s40199-019-00271-6. Epub 2019 May 25.

Application of the combinatorial approaches of medicinal and aromatic plants with nanotechnology and its impacts on healthcare

Priyanka Kumari  1   2 , Suaib Luqman  1   2 , Abha Meena  3   4
Affiliations
Review

Application of the combinatorial approaches of medicinal and aromatic plants with nanotechnology and its impacts on healthcare

Priyanka Kumari et al. Daru. 2019 Jun.

Abstract

Background: Medicinal and aromatic plants are natural raw materials. Since ancient times these herbal materials are being commonly used as herbal drugs, food products, and cosmetics. The phytomolecules isolated from the medicinal and aromatic plants (MAPs) are in high demand specifically in drug industries. However, these phytomolecules have certain limitations of low absorption, high toxicity, and other side effects, bioavailability and efficacy. These limitations may be overcome by using nanotechnological tools. The plant extract or essential oil of MAPs are also useful in the synthesis of nanoparticles. In future this combinatorial application of MAPs and nanotechnology would be advantageous in the healthcare area.

Methods: Literature search was performed using databases like Pubmed, Scopus and Google Scholar with the keywords "nanoparticles," "phytomolecules," "medicinal and aromatic plants" and "green synthesis of nanoparticles" in the text.

Result: Phytomolecules of medicinal and aromatic plants like curcumin, camptothecin, thymol, and eugenol have certain limitations of bioavailability, efficacy, and solubility. It limits its biological activity and therefore application in the biomedical area. The increment in the biological activity and sustained delivery was observed after the encapsulation of these potent phytomolecules encapsulated in the nanocarriers. Besides, MAPs and/or their molecules/oils mediate the synthesis of metal nanocarriers with less toxicity.

Conclusion: This review highlights the impact of the combination of the MAPs with the nanotechnology along with the challenges. It would be an effective technique for the efficient delivery of different phytomolecules and also in the synthesis of novel nano-materials, which escalates the opportunity of exploration of potential molecules of MAPs. Graphical abstract Graphical representation of the combinatorial approach of MAPs and nanotechnology.

Keywords: Aromatic; Biological activity; Medicinal; Nanoparticles; Plants.

PubMed Disclaimer

Conflict of interest statement

The author(s) confirm that this article content has no conflict of interest.

Figures

Graphical abstract
Graphical abstract
Graphical representation of the combinatorial approach of MAPs and nanotechnology.
See this image and copyright information in PMC

References

    1. Sen S, Chakraborty R. Revival, modernization and integration of Indian traditional herbal medicine in clinical practice: importance, challenges and future. J Tradit Complement Med. 2017;7(2):234–244. - PMC - PubMed
    1. Bilia AR, Guccione C, Isacchi B, Righeschi C, Firenzuoli F, Bergonzi MC. Essential oils loaded in nanosystems: a developing strategy for a successful therapeutic approach. Evid Based Complement Alternat Med. 2014;2014. - PMC - PubMed
    1. Adorjan B, Buchbauer G. Biological properties of essential oils: an updated review. Flavour Fragr J. 2010;25(6):407–426.
    1. Bobo D, Robinson KJ, Islam J, Thurecht KJ, Corrie SR. Nanoparticle-based medicines: a review of FDA-approved materials and clinical trials to date. Pharm Res. 2016;33(10):2373–2387. - PubMed
    1. Havel HA. Where are the Nanodrugs? An industry perspective on development of drug products containing nanomaterials. AAPS J. 2016;18(6):1351–1353. - PubMed

LinkOut - more resources